Medicare Enrolled
Dr. Ajay Ajmani, MD
Rheumatology · Sanford, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ajmani from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ajmani?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ajmani
Dr. Ajay Ajmani is a rheumatology specialist in Sanford, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Ajmani performed 3,059 Medicare services across 598 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ajmani received a total of $6,695 from 56 pharmaceutical and/or device companies across 398 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ajmani is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ 3,059 Medicare services
$6,695 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,059
Medicare services
Bottom 40% in NC for rheumatology
598
Unique beneficiaries
$46
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~153 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
641 | $0 | $5 |
| Home visit, established patient, moderate complexity A home visit for an established patient involving moderate medical decision making. The visit requires at least 40 minutes of time if time is used to determine the level of service. |
622 | $95 | $202 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
385 | $82 | $200 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
333 | $45 | $75 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
226 | $10 | $40 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
202 | $0 | $13 |
| Drug screening test A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample. |
179 | $61 | $150 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
124 | $61 | $150 |
| Home visit, established patient, low complexity A physician visits an existing patient at their residence to provide care involving a low level of medical decision making. The visit lasts at least 30 minutes. |
50 | $5 | $200 |
| Quadrivalent influenza vaccine, cell-culture derived A flu shot containing four strains of influenza virus, produced using cell culture technology rather than eggs. This formulation is free from preservatives and antibiotics. |
49 | $33 | $60 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
49 | $29 | $40 |
| Annual depression screening | 46 | $18 | $26 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
44 | $38 | $75 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
37 | $3 | $20 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
36 | $124 | $227 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
24 | $107 | $296 |
| Home visit, new patient, moderate complexity A home visit for a new patient involving moderate medical decision making, lasting at least 60 minutes. |
12 | $100 | $300 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$6,695
Total received (2018-2024)
Avg $956/year across 7 years
Top 36% in NC for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
56
Companies
398
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,490 (96.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$204 (3.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$925
2023
$815
2022
$1,138
2021
$1,019
2020
$903
2019
$1,018
2018
$877
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$277
Amgen Inc.
$186
Fresenius Kabi USA, LLC
$155
PFIZER INC.
$70
Novartis Pharmaceuticals Corporation
$28
Mylan Specialty L.P.
$26
Pharming Healthcare, Inc.
$25
UCB, Inc.
$24
E.R. Squibb & Sons, L.L.C.
$22
Janssen Biotech, Inc.
$21
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$21
Lilly USA, LLC
$20
ABBVIE INC.
$20
Sumitomo Pharma America, Inc.
$17
AstraZeneca Pharmaceuticals LP
$15
Top 3 companies account for 66.8% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$792
Amgen Inc.
$762
PFIZER INC.
$504
Janssen Biotech, Inc.
$454
AstraZeneca Pharmaceuticals LP
$431
Indivior Inc.
$311
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$306
UCB, Inc.
$282
Mallinckrodt Hospital Products Inc.
$281
Novartis Pharmaceuticals Corporation
$248
Supernus Pharmaceuticals, Inc.
$208
AbbVie Inc.
$182
Melinta Therapeutics, LLC
$162
Fresenius Kabi USA, LLC
$155
ABBVIE INC.
$114
Lilly USA, LLC
$106
Mallinckrodt LLC
$88
Mallinckrodt Enterprises LLC
$83
US WorldMeds, LLC
$81
Genentech USA, Inc.
$77
Melinta Therapeutics, Inc.
$74
E.R. Squibb & Sons, L.L.C.
$61
Boehringer Ingelheim Pharmaceuticals, Inc.
$60
Sunovion Pharmaceuticals Inc.
$59
Otsuka America Pharmaceutical, Inc.
$52
USWM, LLC
$50
Sumitomo Pharma America, Inc.
$45
Vanda Pharmaceuticals Inc.
$44
AbbVie, Inc.
$43
Smith & Nephew, Inc.
$43
SANOFI-AVENTIS U.S. LLC
$39
BioCryst Pharmaceuticals, Inc.
$34
Ironwood Pharmaceuticals, Inc
$32
Alkermes, Inc.
$29
Bayer HealthCare Pharmaceuticals Inc.
$29
Eisai Inc.
$26
GlaxoSmithKline, LLC.
$26
Mylan Specialty L.P.
$26
Horizon Therapeutics plc
$26
Pharming Healthcare, Inc.
$25
Celgene Corporation
$20
Aurinia Pharma U.S., Inc.
$20
Exact Sciences Corporation
$19
Shire North American Group Inc
$18
FIDIA PHARMA USA INC.
$17
Alexion Pharmaceuticals, Inc.
$17
Corcept Therapeutics
$16
Lundbeck LLC
$16
Ironshore Pharmaceuticals Inc.
$16
Daiichi Sankyo Inc.
$15
BOSTON SCIENTIFIC CORPORATION
$14
BioCryst US Sales Co., LLC
$13
BioDelivery Sciences International, Inc.
$12
Synergy Pharmaceuticals Inc
$12
Purdue Pharma L.P.
$12
Allergan Inc.
$11
Top 3 companies account for 30.7% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AIRSUPRA · ANORO · APTIOM · AVSOLA · BELBUCA · BREZTRI AEROSPHERE · BYDUREON · Baxdela · CHANTIX · COSENTYX · CREON · Cimzia · Cologuard Collection Kit · Dayvigo · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · Enbrel · FARXIGA · FIRAZYR · GEMTESA · GENERAL PAIN MANAGEMENT · HETLIOZ · HYALGAN · Humira · IDACIO · INJECTAFER · Jornay 100 mg capsules (Bottle of 100) · KRYSTEXXA · Kerendia · Kimyrsa · Korlym · LINZESS · LUPKYNIS · LYRICA · Linzess · Lucemyra · Lucemyra/Lofexidine · NUEDEXTA · OFEV · ORENCIA · OXTELLAR XR · Orbactiv · Orladeyo · Otezla · Ozempic · PREVNAR 20 · QULIPTA · REMICADE · REXULTI · RINVOQ · RUCONEST · RYBELSUS · Rituxan · Rybelsus · SIMPONI · SIMPONI ARIA · SOLIRIS · SPIRIVA RESPIMAT · STELARA · STIOLTO RESPIMAT · SUBLOCADE · SUBOXONE SUBLINGUAL FILM · SYMBICORT · SYMPROIC · Santyl · Saxenda · TALTZ · TAVNEOS · TOUJEO · TOVIAZ · TRELEGY ELLIPTA · TREMFYA · TROKENDI XR · TRULICITY · Tresiba · Trulance · Tyenne · UBRELVY · VIVITROL · VRAYLAR · VYEPTI · Vabomere · Victoza · XELJANZ · XIFAXAN · YUPELRI
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Rheumatologists within 10 mi
3
Per 100K population
4.6
County median income
$63,060
Nearest hospital
CENTRAL CAROLINA HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ajmani is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ajmani experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Ajmani performed 641 dexamethasone injection (steroid) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ajmani receive payments from pharmaceutical companies?
Yes. Dr. Ajmani received a total of $6,695 from 56 companies across 398 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ajmani's costs compare to other rheumatologists in Sanford?
Dr. Ajmani's average Medicare payment per service is $46. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ajmani) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Sanford
Browse rheumatologists in Sanford ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in NC
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in NC
Which NC rheumatologists receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology